Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR 1, expanding the eligibility of ...

SANTA CLARA, Calif., March 10, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications ...

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications Agilent Technologies Inc. (NYSE: A) today ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR 1 ...

For all the buzz surrounding Ozempic and similar GLP-1 drugs for weight loss, there are also plenty of concerns about potential serious or long-term side effects. Among the scariest of these fears ...

Lawmakers from Northeast Georgia are advocating for research and investigative efforts into unusually high thyroid cancer cases in the area. According to Centers for Disease Control and Prevention ...

There are lots of ways to treat thyroid cancer. The treatment you get will depend on the type and stage of the cancer. It also depends on your age, general health, and other things that are unique ...

Thyroid cancer is fairly rare. And thanks to very good treatments, it can be cured most of the time. The type of treatment you get depends on what kind of thyroid cancer you have, and if it has ...

Background: Anaplastic thyroid cancer (ATC), while rare, carries a uniformly poor prognosis. Current treatment includes surgery when possible, radiotherapy, and chemotherapy. Multiple chemotherapeutic ...